We may use cookies to improve your experience with our website and to provide you with more relevant content based on your interests. To learn more about what information we collect, how we use it, and how to manage cookies, review our Privacy Policy.

Watch Exact Sciences Chairman and CEO Kevin Conroy's Appearance on CNBC's Mad Money

Last Friday, Exact Sciences Chairman and CEO Kevin Conroy appeared on CNBC's Mad Money to discuss Cologuard, Exact Sciences' FDA-approved noninvasive stool DNA screening test for colorectal cancer (available by prescription only).

You can watch a clip of Conroy's appearance below. For other investor content, view our investor site or investor blog.

 

 

Topics: Investor Relations

Subscribe To The Blog